Nutraceuticals

Algae is emerging as one of the most promising source of sustainable crops with potential health benefits including protein, Omega 3 and anti oxidants. The nutraceutical and pharmaceutical potential of the large variety of algae species is just starting to be explored. Our innovative photobioreactor systems aims to harness and manipulate sunlight to induce the generation of antioxidants and other high value products from a select group of algae species.

 

PAS, our patented technology, aims to enhance particular pigments and products within certain algae species that have nutritional, nutraceutical or pharmaceutical value. These new dyes target valuable anti-oxidants and compounds produced by algae that are extremely sensitive to the intensity and colour of light received by algae. By delivering particular colours of light to the algae cultures we aim to induce the algae to produce more of the desired product.

 

 

PAS aims to increase algae biomass and affect the pigments compounds produced by the algae themselves, with the objective of greater yields of high-value products in a controlled environment at significantly lower cost than traditional closed photobioreactors.

Health Benefits

Algae are a rich and varied source of pharmacologically active natural products and nutraceuticals. While nutraceutical and pharmaceutical content in the baseline algae strain is very small, current market values for these products are extremely high. The major products currently being commercialized or under consideration for commercial extraction include carotenoids, phycobilins, fatty acids, polysaccharides, vitamins, sterols, and biologically active molecules for use in human and animal health. The upcoming sections will bring into focus the use of algae as a potential source of pharmaceutical and nutraceutical ingredients.

 

 

 

 

Algae as a Source of Pharmaceuticals

Pharmaceutical industry is growing at a CAGR of around 8% while the global pharmaceutical market is forecasted to reach US$ 1043.4 billion in 2012.

Use of algae, especially the cyanobacteria (blue-green algae), for antibiotics and pharmacologically active compounds has received ever increasing interest. There are a range of pharmaceutical products derived from algae. Some of them include:

  • Antimicrobials, Antivirals & Antifungals
  • Neuroprotective Products
  • Therapeutic proteins
  • Drugs

Algae as a Source of Nutraceuticals

The growing use of algae biomass for nutraceutical purposes is expected to provide an attractive revenue stream for algae producers. While nutraceutical content in the baseline algae strain is very small, current market values for these products are extremely high.

Physiologically-active nutraceuticals from algae include food supplements, dietary supplements, value-added processed foods as well as non-food supplements such as tablets, soft gels, capsules etc.

Some of the noteworthy products that can be derived from algae:

  • Omega 3 polyunsaturated fatty acids (PUFA)
  • Carotenoids
  • Astaxanthin
  • β-Carotene

The markets for both pharmaceuticals and nutraceuticals are growing quickly worldwide, and it is this global scope that particularly attracts marketers. A growing proportion of today’s promising pharmaceutical and nutraceutical research focuses on the production of promising compounds from algae. Thus, the untapped potential of algae in the field of pharmaceuticals and nutraceuticals has to be still explored to grow and capitalize on tremendous global marketing opportunities

---

References

Algae as a Source of Pharmaceuticals & Nutraceuticals, oilgae.com, http://oilgae.com/blog/2010/09/algae-as-a-source-of-pharmaceuticals-nutraceuticals

Go to top